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Abstract
Objetives: The aim of this study was to investigate the existence of correlation between the TNM clinical classification, 
anatomical location and prognosis of oral squamous cell carcinoma. Study design: A total of 130 oral squamous 
cell carcinomas were selected from the files of the Dr. Luiz Antonio Hospital (Natal, Rio Grande do Norte, Brazil). 
Data concerning TNM clinical classification, anatomical location and prognosis were obtained. Pearsons correlation 
test was applied for the statistical analysis of data. Results: It revealed a statistically significant correlation (p = 0.01) 
between TNM clinical classification and prognosis. It also revealed correlation between TNM classification and the 
anatomical location of oral squamous cell carcinomas (p = 0.01). Conclusions: We concluded that TNM classification 
presented correlation with prognosis and with the different anatomical locations of oral squamous cell carcinomas.
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Introduction
The TNM clinical staging system is very effective, mainly 
for assessing the fundamental characteristics of a cancer, 
such as local extent, regional dissemination and distant 
metastasis (1,2). Advanced TNM stages (III and IV) are 
related to poor prognosis in patients with oral squamous 
cell carcinoma (3).
Bilateral metastases of the cervical ganglia in patients with 
oral oral squamous cell carcinoma have poorer prognosis 
than those with unilateral metastasis (4). The level of lym-
ph node involvement is an important prognostic factor, 
given that it diminishes significantly patient survival when 
multiple contralateral lymph nodes are involved (5, 6).
TNM stages III and IV are more closely related to the 
presence of neural infiltration and lymphatic embolization 
in patients with oral oral squamous cell carcinoma, thus 
showing that patients with clinical stage IV present with 
active or recurring disease (7, 8) and have lower survival 
time, whereas, those with TNM I and II are disease-free 
after 5 year follow-up (9).
The anatomic location of the lesion must also be consi-
dered as a prognostic indicator, since the tumors behave 
differently depending on anatomic location (10,11). Any 
region of the oral cavity can be affected by in oral squa-
mous cell carcinoma, mainly the tongue (12,13), the floor 
of the mouth (4,11,12) and the lower lip (13).
T2 lesions of the tongue are more likely to recur and are 
more intimately related to cervical lymph node metastases, 
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thus showing the close relation between histopathological 
findings (mainly form and stage) and prognoses (11). 
Oral squamous cell carcinoma of the tongue has greater 
risk of metastasis to the cervical lymph nodes due to the 
lesion’s proximity to this anatomic site. In addition, the 
histological malignancy score of most of these lesions was 
high (between 2.5 and 4.0) (14).
The TNM clinical classification record and anatomic lo-
cation of the oral squamous cell carcinoma are of utmost 
importance in determining prognosis and treatment, since 
tongue and the floor of the mouth lesions are associated 
with higher risk of developing the advanced stage and 
consequent recurrence (1,4,15).
The most important challenge to the TNM system is how 
it deals with the large number of non-anatomic prognostic 
factors that are being widely used. The role of the TNM 
system when associated to other prognostic factors is to 
determine the therapeutic choice, select patients for the-
rapeutic studies, in addition to assessing non-anatomic 
prognostic factors in specific anatomic stages and com-
municating the extent of the disease (16). 
Chen et al. (17) suggested that predictive factors in oral 
and pharyngeal carcinoma survival are: ethnic groups, 
period of diagnosis, gender, diagnostic age, anatomic site, 
morphologic type, and therapy. These data are useful to 
researchers investigating the long-term survival trends for 
subjects diagnosed with oral and pharyngeal cancer.
The purpose of this study was to correlate clinical TNM 
staging with prognosis and anatomic location in 130 cases 
of oral squamous cell carcinoma.
Material and Methods
1- Population
It consisted of all the cases of oral squamous cell carci-
noma on file at Dr. Luiz Antônio Hospital in Natal/RN, 
Brazil from 2000 to 2005.
2- Sample
 The sample selected consisted of 130 cases of oral squa-
mous cell carcinoma in patients treated and recorded in 
the files of Dr. Luiz Antônio Hospital. With the analysis 
of the medical records, data were obtained relative to the 
patient’s sex, age group, anatomic location of the lesion 
and TNM clinical classification. These data were selected 
according to the following parameters:
*Sex and skin color: men and women with white, brown 
or black skin.
* Age: in age groups, from the 4th decade.
* Location of the lesion: the lesion was analyzed if  it was 
located on the tongue, lower lip, the floor of the mouth, 
the orapharynx or jugal mucosa, alveolar mucosa and 
retromolar area. 
*TNM clinical staging: according to the version establis-
hed by the International Union Against Cancer (UICC) 
(Hermaneck et al. (18), 1996; Neville et al. (19), 2004): 
Stage I = T1N0M0; Stage II = T2N0M0; Stage III = 
T3N0M0, or T1, T2 or T3N1M0;  Stage IV = any T4, 
N2, N3 or M1 lesion.
* Prognosis: We analyzed, after a maximum period of 
5 years, if  the patients were disease free, had the disease 
(stable or ongoing), had recurring lesions (after treatment) 
or had died. We also divided them into two groups: the 
first group, consisting of disease-free patients, was consi-
dered to have the best prognosis and the second, formed 
by those with the disease (stable, recurring and ongoing) 
or who had died as a result of the neoplasias, to have the 
worst prognosis.
Medical records that contained incomplete or confusing 
information on clinical variables were excluded.
Statistical analysis
We used Pearson’s paired t-test to determine the correla-
tion between clinical TNM classification and prognosis 
and anatomic location of the lesion. In all the tests applied, 
a level of 5% was set to reject the null hypothesis.
Results 
- Quantitative results
Based on the analysis of the data of patients with oral 
squamous cell carcinoma, we observed that of the 130 case 
analyzed, 70 (53.84%) were of men (M) and 60 (46.15%) 
were of women (W), with a ratio M/W of 1.16/1. The 
brown people (65%) were more commum in our sample. 
Ages varied from 40 to 93 years with 15 cases (11.53%) 
in the 41- 50- year group, 20 cases (15.38%) in the 51- 60- 
year group, 30 cases (23.07%) in the 61-70-year group, 
40 cases (30.76%) in the 71-80-year group, 20 (15.38%) 
in the 81-90-year group and 05 cases (3,84%) in the 91-
93-year group.
According to clinical TNM classification, our sample was 
distributed as follows: 29 cases (22.3%) were classified as 
T1, 17 cases (13.07%) as T2, 33 cases (25.38%) as T3 and 
51 cases (39.23%) as T4.
By grouping the clinical stages into I/II and III/IV, we 
observe the following results for clinical staging (TNM) 
and prognosis.
1) A correlation between clinical staging (TNM) and 
prognosis.
2) Of the 46 cases classified as stage I and II, 5 patients 
had recurring lesions, 3 had  active lesions, 1 had died and 
37 were disease-free.
3) Of the 84 cases classified as stage III and IV, 38 were 
disease-free, 11 had active lesions, 16 had recurring lesions 
and 19 had died.
With respect to anatomic location, the area most affected 
by oral squamous cell carcinoma was the side of the ton-
gue with 52 cases (40%), followed by the lower lip with 26 
cases (20%) and palate with 16 cases (16.2%). Squamous 
cell carcinoma lesions on the side of the tongue were pre-
sent in 38 cases (45.2%) of the patients with clinical stages 
III/IV, while 19 cases (41.3%) with stages I/II presented 
with oral epidermoid carcinoma on the lower lip.
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Table 1. Correlation between TNM clinical staging and prognosis in oral epidermoid carcinoma. 
Dr. Luis Antônio Hospital, Natal, Brazil (2007).
- Statistical analysis results
Pearson’s test showed a statistically significant correlation 
between TNM clinical classification and prognosis of oral 
squamous cell carcinoma when the second group variable 
is analyzed (group I – disease-free and group II- with the 
disease and death) (p = 0.01) (Table 1). The correlation 
between TNM clinical staging (I/II; III/IV) and anatomic 
location also shows a correlation at the 1% level (p = 0.01) 
(Table 2).
Discussion
 It was observed that 33.3% of the cases clinically classified 
as TNM stage 1 were disease-free, as were 16.0% of the 
patients with TNM stage II after 5 years follow-up. We 
found that 30.9% of patients with TNM stage III had the 
disease or had died. Stage IV was present in 52.7% of the 
patients who had the disease or who had succumbed to it. 
The results were statistically significant (p = 0.01) when the 
correlation was performed with grouped prognosis varia-
bles. TNM clinical staging I and II were most observed in 
Prognosis
Disease 
free
Disease 
and death
Total p
TNM clinical 
staging
I
Count 25 4 29
0.01
% with TNM 
clinical staging
86,2% 13,8% 100,0%
% with prognosis 33,3% 7,3% 22,3%
II
Count 12 5 17
0.01
% with TNM 
clinical staging
70,6% 29,4% 100,0%
% with prognosis 16,0% 9,1% 13,1%
III
Count 16 17 33
0.01
% with TNM 
clinical staging
48,5% 51,5% 100,0%
% with prognosis 21,3% 30,9% 25,4%
IV
Count 22 29 51
0.01
% with TNM 
clinical staging
43,1% 56,9% 100,0%
% with prognosis 29,3% 52,7% 39,2%
Total
Count 75 55 130
0,001
% with TNM 
clinical staging
57,7% 42,3% 100,0%
% with prognosis 100,0% 100,0% 100,0%
TNM clinical   staging
I/II III/IV Total
Anatomic 
location
The floor of the 
mouth
 N               % N            % N              % p
1               2,2 6              7,1 7             5,4 0.01
Tongue 14           30,4 38          45,2 52         40 0.01
Lower lip 19           41,3 7              8,3 26         20 0.01
Orapharynx 1               2,2 10          11,9 11           8,5 0.01
Palate 6             13 15          17,9 21         16,2 0.01
Maxillary alveolar 
mucosa
4               8,7 3              3,6 7             5,4 0.01
Retromolar area 1               2,2 5              6,0 6             4,6 0.01
Total 46            100 84         100 130        100 0.01
Table 2. Correlation between anatomic location of oral epidermoid carcinoma and TNM clinical 
staging. Dr. Luis Antônio Hospital, Natal, Brazil (2007).
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disease-free patients whereas individuals with ongoing or 
recurring disease or who had died were the most prevalent 
in TNM clinical staging III and IV. Woolgar et al. (6), 
Numata et al. (7), and Dib et al. (8) report a strong corre-
lation between TNM clinical classification and survival in 
patients with oral squamous cell carcinoma.
Many authors consider TNM clinical staging to be one 
of the best prognostic indicators of oral squamous cell 
carcinoma (9,14,18). Other studies have shown a strong 
correlation between TNM clinical classification and the 
survival of  patients with oral epidermoid carcinoma 
(6,7,8,15). However, other prognostic parameters should 
be used, such as the biological properties of the tumor, 
to corroborate the prognostic value of the TNM system 
and the treatment plan (2,3).
Our results showed a statistically significant correlation at 
1% (p = 0.01) between TNM clinical staging and anato-
mic location of the lesion. Stage I clinical cases occurred 
mostly in patients with lower lip lesions, whereas most of 
the tongue lesion cases were stage III or IV. Most of the 
floor of the mouth and soft palate cases were classified as 
T4. Our findings suggest that these locations (tongue, soft 
palate and floor of the mouth) present the worst prognosis 
for oral squamous cell carcinoma. These data corrobo-
rate those of Costa et al. (1,14), who consider anatomic 
location an important prognostic indicator, given that 
the lower lip lesions are generally well differentiated from 
those that affect the tongue and roof of the mouth.
Costa et al. (1) found that lower lip tumors often have bet-
ter prognosis when compared to other oral cavity locations. 
According to Dib et al. (8) and Urist et al. (10), squamous 
cell carcinoma carcinomas of the tongue and floor of the 
mouth generally have poor prognosis due to the frequent 
presence of cervical metastases. Chen et al. (17) consider 
anatomic sites to be significant predictors for survival in 
Hokkien (Taiwan). Tongue and mouth sites elevated risks 
of death compared with oropharyngeal, but lip sites had 
a significantly better prognosis (17). 
Our results show that some factors such as the anatomic 
location of  the lesion and TNM clinical classification 
are important prognostic indicators in patients with Oral 
squamous cell carcinoma, since there was a statistically 
significant correlation between TNM clinical classifica-
tion, prognosis and anatomic location. For this reason, 
early diagnosis of  this neoplasia, along with improved 
awareness on the part of dental surgeons, may contribute 
to better survival rates and quality of life in patients with 
oral squamous cell carcinoma.
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